Since TAM and other myeloid cells display the highest immune expression of PD-L1 in the tumor microenvironment of BC (30, 134), reducing the representation of these potentially immunosuppressive cell populations is the goal of several therapeutic strategies for modulation of the tumor immune microenvironment (135). This evidence concerns the gene CD274 and breast cancer.